Evidence map›Paper›PMID 27068745›Full record

ArticleThe Journal of biological chemistry2016

An Alzheimer Disease-linked Rare Mutation Potentiates Netrin Receptor Uncoordinated-5C-induced Signaling That Merges with Amyloid β Precursor Protein Signaling.

Yuichi Hashimoto, Yuka Toyama, Shinya Kusakari, Mikiro Nawa, Masaaki Matsuoka

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. The role ofAnnals of translational medicine · 2018
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yuichi HashimotoFrom the Departments of Pharmacology and.
Yuka ToyamaFrom the Departments of Pharmacology and.
Shinya KusakariFrom the Departments of Pharmacology and.
Mikiro NawaFrom the Departments of Pharmacology and.
Masaaki MatsuokaFrom the Departments of Pharmacology and Dermatological Neuroscience, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan sakimatu@tokyo-med.ac.jp.
Tokyo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A missense mutation (T835M) in the uncoordinated-5C (UNC5C) netrin receptor gene increases the risk of late-onset Alzheimer disease (AD) and also the vulnerability of neurons harboring the mutation to various insults. The molecular mechanisms underlying T835M-UNC5C-induced death remain to be elucidated. In this study, we show that overexpression of wild-type UNC5C causes low-grade death, which is intensified by an AD-linked mutation T835M. An AD-linked survival factor, calmodulin-like skin protein (CLSP), and a natural ligand of UNC5C, netrin1, inhibit this death. T835M-UNC5C-induced neuronal cell death is mediated by an intracellular death-signaling cascade, consisting of death-associated protein kinase 1/protein kinase D/apoptosis signal-regulating kinase 1 (ASK1)/JNK/NADPH oxidase/caspases, which merges at ASK1 with a death-signaling cascade, mediated by amyloid β precursor protein (APP). Notably, netrin1 also binds to APP and partially inhibits the death-signaling cascade, induced by APP. These results may provide new insight into the amyloid β-independent pathomechanism of AD.

Indexed as

Mutation, MissenseAlzheimer DiseaseAmyloid beta-Protein PrecursorAnimalsApoptosisBlotting, WesternCalcium-Binding ProteinsCaspasesCell LineCell Line, TumorDeath-Associated Protein KinasesHumansMAP Kinase Kinase Kinase 5Mitogen-Activated Protein Kinase 8NADPH OxidasesNerve Growth FactorsAmyloid beta-Protein PrecursorCalcium-Binding ProteinsCALML5 protein, humanCaspasesDeath-Associated Protein KinasesMAP3K5 protein, humanMAP Kinase Kinase Kinase 5Mitogen-Activated Protein Kinase 8NADPH OxidasesNerve Growth FactorsNetrin-1Netrin ReceptorsNTN1 protein, humanProtein Kinase Cprotein kinase DReceptors, Cell SurfaceTumor Suppressor ProteinsUNC5C protein, humanAlzheimer diseaseamyloid beta-independentamyloid precursor protein (APP)apoptosisneurodegenerative diseaseneuronal cell deathsignal transductionUNC5C

Identifiers

PMID27068745
PMCPMC4933276
OpenAlexW2324327757

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.